Medicxi Ventures is a venture capital firm investing in life sciences, with a particular focus on therapeutics. The firm invests at the very early-stage of drug development, when candidate drugs have just been discovered and are entering preclinical ...Show all
Phone: +44 20 7952 1788
25 Great Pulteney Street
London, W1F 9LT
England, United Kingdom
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-12-01 | RayzeBio | Series B | $105M | Alexandria Venture Investments, Cormorant Asset Management, LifeSci Venture Partners, Logos Capital, OrbiMed Advisors, Redmile Group, Samsara BioCapital, venBIO, Venrock, Versant Ventures, and Viking Global Investors |
2020-11-19 | SynOx Therapeutics | Series A | $43.77M | Forbion Capital Partners, Gimv, and HealthCap Venture Capital |
2020-10-14 | RayzeBio | Series A | $45M | Samsara BioCapital, venBIO, and Versant Ventures |
2020-10-07 | Janpix | Series B | $10M | |
2020-09-25 | Palladio Biosciences | Series B | $20M | Osage University Partners, Roche Venture Fund, and Samsara BioCapital |